Oestrogen therapy for urinary incontinence in post-menopausal women (Q24240302)

2

0 references

Birgit Moehrer

3

0 references

Andrew Hextall

4

0 references

Cathryn MA Glazener

Cochrane Database of Systematic Reviews

5

0 references

publication date

7 October 2009

0 references

published in

0 references

cites work

Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women--a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Baseline health-related quality of life in postmenopausal women with coronary heart disease: the Estrogen Replacement and Atherosclerosis (ERA) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Effects of estrogen with and without progestin on urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Effects of oral estrogen and progestin on the lower urinary tract among female nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Presurgical promestriene therapy in postmenopausal women with stress urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Role of estrogens in the treatment of female urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Micturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Postmenopausal hormone therapy: does it cause incontinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Short-term urogenital effects of raloxifene, tamoxifen, and estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure-a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Effect of raloxifene on urinary incontinence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Adrenergic drugs for urinary incontinence in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Traditional suburethral sling operations for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Minimally invasive sling operations for stress urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Laparoscopic colposuspension for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Anterior vaginal repair for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Urodynamic investigations for management of urinary incontinence in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Bladder neck needle suspension for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Which anticholinergic drug for overactive bladder symptoms in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Weighted vaginal cones for urinary incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Prevalence of genito-urinary symptoms in the late menopause

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Pelvic floor muscle training in combination with another therapy compared with the other therapy alone for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Open retropubic colposuspension for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Pelvic floor muscle training versus other active treatments for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Mechanical devices for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Prevalence of urinary incontinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Measuring patients' views: the optimum outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Oestrogens for urinary incontinence in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

Anticholinergic drugs versus other medications for overactive bladder syndrome in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Periurethral injection therapy for urinary incontinence in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Estrogen receptors in the human female lower uninary tract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Oestriol in the treatment of postmenopausal urgency: a multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Estrogen therapy in the management of problems associated with urogenital ageing: a simple diagnostic test and the effect of the route of hormone administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Effect of vulvovaginal estrogen on sensorimotor response of the lower genital tract: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

[Intravesical administration of estriol in sensory urge incontinence--a prospective study]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

The effectiveness of intravaginal estriol tablet administration in women with urge incontinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Urogenital ageing and its effect on sexual health in older British women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

A new questionnaire to assess the quality of life of urinary incontinent women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Reported prevalence of urinary incontinence in women in a general practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Clinical effects of preoperative oestradiol treatment before vaginal repair operation. A double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021

The effects of estrogens and gestagens on the urethral pressure profile in urinary continent and stress incontinent women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001405.PUB2

7 January 2021